Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hutchmed China Ltd (13 HK)
Watchlist
177
Analysis
Industrials
•
Hong Kong
HUTCHMED (China) Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hutchmed China Ltd
•
20 Feb 2024 08:55
Hutchmed China Ltd (13.HK/HCM.US) - 2023 Results Preview and Catalysts in 2024
HUTCHMED has entered a harvest period.Product revenue would grow rapidly in the next two years, with promising catalysts head.Together with...
Xinyao (Criss) Wang
Follow
329 Views
Share
bullish
•
Alibaba Group Holding
•
14 Dec 2022 09:38
China ADRs Delisting - Friday Could Be Judgment Day for over US$800bn Mcap of Stocks
PCAOB officials concluded their Hong Kong visit last month and PCAOB is due to announce its annual judgment on whether it had adequate access to US...
Sumeet Singh
Follow
890 Views
Share
bullish
•
KraneShares CSI China Internet ETF
•
03 Apr 2022 21:50
New CSRC "Provisions" Take a Step Towards Meeting PCAOB Requirements
CSRC has published new Provisions putting the onus of info management on companies, making it easier for the PCAOB to conduct on-site audits. It...
Travis Lundy
Follow
327 Views
Share
bullish
•
Hutchmed China Ltd
•
20 Dec 2023 08:55
Hutchmed China Ltd (13.HK/HCM.US) - A Valuable Option in the Portfolio
Despite market's lackluster response to fruquintinib’s FDA approval, we're optimistic about HUTCHMED’s outlook.Rich cash flow/future catalysts make...
Xinyao (Criss) Wang
Follow
444 Views
Share
bullish
•
Hutchmed China Ltd
•
10 Nov 2023 19:31
•
Broker
Hutchmed (13 HK) – Big Milestone Achieved with Fruquintinib Successfully Approved by US FDA
The approval was based on the Ph3 MRCT FRESCO-2 (18% patients enrolled from the US) as well as the China FRESCO trial, implying the recognition of...
CMB International
Follow
379 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x